FDA Inspection
N-Molecular Inc. d.b.a. SOFIEN-Molecular Inc. d.b.a. SOFIE – FDA Inspection, Feb 28, 2018
Record Details
This FDA Inspection record concerns N-Molecular Inc. d.b.a. SOFIE, with an inspection on February 28, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 2bbd64a6-f0fc-4130-bfdb-66bf35e049d4
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1042553
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 212.20(e)Written QA procedures established, followed
- 21 CFR 212.30(b)Equipment not clean
- 21 CFR 212.30(b)Equipment procedures overall
- 21 CFR 212.30(b)Equipment not suitable
- 21 CFR 212.30(a)Prevention of contamination
- 21 CFR 212.50Adequate controls (general)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of N-Molecular Inc. d.b.a. SOFIE
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 20, 2024 | VAI | New England District Office | Drug Quality Assurance |
| May 16, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 7, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 11, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for N-Molecular Inc. d.b.a. SOFIE
- FDA Inspection 1250020 - 2024-11-20
- FDA Inspection 1089718 - 2019-05-16
- FDA Inspection 939620 - 2015-08-07
- FDA Inspection 859853 - 2013-12-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.